Experience

Picket Pharmaceuticals
• United States
• Pharmaceutical Manufacturing
• 1 - 100 Employee
• Chief Executive Officer

  • Mar 2018 - Present


Columbia University Medical Center - ICAP

• Program Manager - PHIA Project

  • Oct 2015 - Feb 2019

  The PHIA Project Program Manager is responsible for oversight and management of statistical analyses, staffing, ensuring that the statistical operations of the PHIA project and milestones are met. Additional responsibilities include developing and maintaining systems and standardizing processes to track and report ICAP usages, projects and outcomes. The Analytics Manager manages the Statistical Analysis Center's (SAC) day to day statistical operations, the management and development of new proposals, requests for statistical support, and tracking project estimates/budgets, in a proactive, standardized fashion. Show less



Columbia University Medical Center

• United States
• Medical Practices
• 1 - 100 Employee

• Lead Statistician

  • 2014 - Oct 2018

  Titile: Intranasal Ketorolac Versus Intravenous Ketorolac for Treatment of Migraine Headaches in Children: A Randomized Non-inferiority Clinical TrialClinicaltrial.gov identifier: NCT02358681Description: Ketorolac is an evidence-based, first-line acute migraine therapy that is commonly used in the pediatric population; however, it is typically administered by the intravenous (IV) or intramuscular (IM) routes, both of which require a painful and distressing needle stick to administer.The intranasal (IN) route is a painless and effective way of administering analgesics, including ketorolac: IN ketorolac has been shown to be an effective analgesic in adults for painful conditions, including acute migraine headaches. However, IN ketorolac has been understudied in children, and it is not known how effective it is compared to IV ketorolac, which is currently the most common way of administering ketorolac to children. If IN ketorolac is shown to be no less effective than IV ketorolac, IN ketorolac may be a viable and painless alternative to effectively treat acute migraine headaches in children.Therefore, our primary aim is to demonstrate that IN ketorolac is non-inferior to IV ketorolac for reducing pain in children with acute migraine headaches. Show less

• Lead Statistician

  • 2014 - 2017

  Title: Sonographic Visualization vs Palpation Technique for Infant Lumbar PunctureClinicaltrial.gov identifier: NCT02373774Description: The investigators are conducting a single-center, prospective two-arm parallel group randomized clinical trial in an urban pediatric emergency department to determine if performing an ultrasound prior to lumbar puncture procedure improves success of the procedure.

• Statistical Program Manager - Novartis Sponsored Analyses of RELAX-AHF Trial (Serelaxin)

  • Jan 2014 - Jan 2016

  Oversee all methods and results conducted and presented to Novartis and the RELAX-AHF clinical trial Executive Committee. Responsible for the development, maintenance, and management of biostatistic functions to support and manage Statistical Analysis Center (SAC) personnel under contract as consultants to Novartis. The Columbia University Medical Center team based out of the SAC provides programming and statistical services necessary for the production of planned analyses, publications, abstract submissions and presentation materials to professional congresses. Show less



Baylor University Medical Center

• Hospitals and Health Care
• 700 & Above Employee

• Lead Statisitician

  • 2014 - Mar 2017

  Title: Citrulline Supplementation for Treatment of Nitric Oxide Deficiency in MELAS: A Phase I Dose-Finding and Safety Study Description: The main purpose of this study is to determine the safest maximal dose of an amino acid, citrulline, which will be used as potential treatment for adult patients with a disorder of energy metabolism called Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS). Once established, this dose will be used in a future clinical trial. This study will use the Time-To-Event (TITE) Continual Reassessment Method (CRM) design to establish the maximum tolerable dose (MTD) of L-citrulline in patients with MELAS. Show less



Aquilonis

• India

• Partner, Director of United States Operations, Vice President of Sales and Marketing

  • 2008 - 2010

  The Aquilonis foundation has been built by a strong team of industry professionals with three decades of combined experience in mobile technology and solutions. Aquilonis operates out of two strategically placed locations in Bangalore, India and Boston, Massachusetts, USA. The core focus of Aquilonis is on building world class products and innovative solutions for a rapidly expanding global Mobile Computing market. The Aquilonis foundation has been built by a strong team of industry professionals with three decades of combined experience in mobile technology and solutions. Aquilonis operates out of two strategically placed locations in Bangalore, India and Boston, Massachusetts, USA. The core focus of Aquilonis is on building world class products and innovative solutions for a rapidly expanding global Mobile Computing market.



eRSVP Inc

• Founder and Chief of Product Development

  • 2004 - 2008

  Improving information delivery using methods developed in neurobiology. Improving information delivery using methods developed in neurobiology.